China Reform Health Management and Services Group Co., Ltd. (SHE:000503)
China · Delayed Price · Currency is CNY 9.34
-0.09 (-0.95%)
Feb 13, 2026, 3:04 PM CST
SHE:000503 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 326.96 | 356.73 | 329.95 | 310.89 | 252.33 | 207.23 |
Other Revenue | 0.17 | 0.17 | 0.17 | 0.19 | 0.19 | 0.14 |
| 327.12 | 356.9 | 330.13 | 311.08 | 252.52 | 207.37 | |
Revenue Growth (YoY) | -11.44% | 8.11% | 6.12% | 23.19% | 21.77% | 59.62% |
Cost of Revenue | 288.3 | 302.45 | 248.14 | 246.62 | 218.69 | 176.92 |
Gross Profit | 38.83 | 54.45 | 81.99 | 64.46 | 33.83 | 30.45 |
Selling, General & Admin | 211.42 | 190.37 | 190.4 | 163.74 | 149.04 | 131.37 |
Research & Development | 1.91 | 0.34 | 0.97 | 9.65 | 16.31 | 16.42 |
Other Operating Expenses | 1.45 | 1.79 | 1.11 | 1.96 | 1.76 | 0.94 |
Operating Expenses | 241.1 | 216.68 | 200.52 | 174.41 | 180.6 | 159.84 |
Operating Income | -202.27 | -162.23 | -118.53 | -109.95 | -146.77 | -129.39 |
Interest Expense | -10.37 | -8.31 | -5.12 | -1.98 | -2.49 | -0.51 |
Interest & Investment Income | 90.72 | 149.54 | 13.12 | 1.58 | 4.25 | 8.21 |
Earnings From Equity Investments | - | - | - | 4.02 | - | - |
Currency Exchange Gain (Loss) | 0.12 | 0.12 | -0.06 | -0.35 | -1.73 | -2.75 |
Other Non Operating Income (Expenses) | -6.59 | -1.27 | -0.71 | 7.09 | -0.76 | 1.9 |
EBT Excluding Unusual Items | -128.38 | -22.14 | -111.3 | -99.59 | -147.51 | -122.53 |
Gain (Loss) on Sale of Investments | 6.34 | 6.34 | 27.27 | 14.42 | -29.47 | -84.65 |
Gain (Loss) on Sale of Assets | -0.03 | 0.03 | 0.11 | 0.01 | 0.04 | - |
Asset Writedown | 0.63 | -0 | -2.71 | -0.37 | -0.05 | -35.42 |
Legal Settlements | - | - | - | - | - | -1.12 |
Other Unusual Items | 3.82 | 4.08 | 8.22 | 2.34 | 0.06 | 0.9 |
Pretax Income | -117.62 | -11.69 | -78.41 | -83.19 | -176.92 | -242.82 |
Income Tax Expense | 0.24 | -0.23 | 1.91 | 1.13 | 0.2 | 0.52 |
Earnings From Continuing Operations | -117.86 | -11.47 | -80.32 | -84.32 | -177.12 | -243.34 |
Net Income to Company | -117.86 | -11.47 | -80.32 | -84.32 | -177.12 | -243.34 |
Minority Interest in Earnings | - | 1.09 | 0.53 | -0.01 | 1.3 | 0.74 |
Net Income | -117.86 | -10.38 | -79.79 | -84.33 | -175.82 | -242.61 |
Net Income to Common | -117.86 | -10.38 | -79.79 | -84.33 | -175.82 | -242.61 |
Shares Outstanding (Basic) | 979 | 979 | 911 | 907 | 901 | 899 |
Shares Outstanding (Diluted) | 979 | 979 | 911 | 907 | 901 | 899 |
Shares Change (YoY) | 0.73% | 7.46% | 0.46% | 0.67% | 0.21% | 0.06% |
EPS (Basic) | -0.12 | -0.01 | -0.09 | -0.09 | -0.20 | -0.27 |
EPS (Diluted) | -0.12 | -0.01 | -0.09 | -0.09 | -0.20 | -0.27 |
Free Cash Flow | -149.05 | -120.11 | -154.28 | -197.87 | -127.95 | -110.71 |
Free Cash Flow Per Share | -0.15 | -0.12 | -0.17 | -0.22 | -0.14 | -0.12 |
Gross Margin | 11.87% | 15.26% | 24.83% | 20.72% | 13.40% | 14.68% |
Operating Margin | -61.83% | -45.45% | -35.91% | -35.34% | -58.13% | -62.39% |
Profit Margin | -36.03% | -2.91% | -24.17% | -27.11% | -69.63% | -116.99% |
Free Cash Flow Margin | -45.56% | -33.65% | -46.73% | -63.61% | -50.67% | -53.39% |
EBITDA | -177.27 | -135.43 | -89.35 | -82.22 | -143.23 | -97.09 |
EBITDA Margin | -54.19% | -37.95% | -27.07% | -26.43% | -56.72% | -46.82% |
D&A For EBITDA | 25.01 | 26.79 | 29.18 | 27.73 | 3.54 | 32.3 |
EBIT | -202.27 | -162.23 | -118.53 | -109.95 | -146.77 | -129.39 |
EBIT Margin | -61.83% | -45.45% | -35.91% | -35.34% | -58.13% | -62.39% |
Revenue as Reported | 327.12 | 356.9 | 330.13 | 311.08 | 252.52 | 207.37 |
Advertising Expenses | - | 0.72 | 0.36 | 0.15 | 0.56 | 0.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.